GENFIT Alternatives & Competitors
12 companies similar to GENFIT — Dedicated to improving the lives of patients with liver diseases characterized b...
Companies similar to GENFIT
Intercept Pharmaceuticals
Our mission is to build a healthier tomorrow for patients with rare and serious liver dise...
Morristown, United States
Madrigal Pharmaceuticals
Madrigal is focused on delivering novel therapeutics for MASH, a serious liver disease.
Conshohocken, United Stat...
Inventiva Pharma
A clinical-stage biopharmaceutical company focused on the development of oral small molecu...
France
CymaBay Therapeutics
Dedicated to improving the lives of patients with liver diseases
Newark, United States
Track all GENFIT competitors
Get real-time alerts when any of these companies raise funding, hire, or show growth signals.
Umecrine Cognition AB
A novel and safe approach for treating cognitive disorders
Solna, Sweden
Resalis Therapeutics
Tackling metabolic disorders with non-coding RNAs
Turin, Italy
NorthSea Therapeutics
Clinical-stage biopharmaceutical company focused on the development of structurally engine...
Amsterdam, The Netherland...
HemoShear Therapeutics
Developing new treatments for rare metabolic disorders
Charlottesville, United S...
Anthera Pharmaceuticals
Pioneering Therapeutics to Combat Inflammatory Diseases, Pioneering Better Health
Acceleron Pharma
Accelerating drug discovery to transform patients' lives
Cambridge, United States
Cirius Therapeutics
Pioneering the future of liver and metabolic disease treatment with innovative insulin sen...
Atom Therapeutics
Atom Therapeutics Co., Ltd
Suzhou, China
About GENFIT
GENFIT is a late-stage biopharmaceutical company with a focus on improving the lives of patients with rare and severe liver diseases characterized by high unmet medical needs. With a history spanning over two decades, the company has shown prowess in developing high-potential assets, exemplified by the successful 52-we...
Biopharmaceutical, Liver Diseases, Metabolic Disorders, Drug Discovery, Drug Development, Clinical Trials, ACLF, Cholestatic Diseases, Diagnostic Tools, Hepatic Encephalopathy, Cholangiocarcinoma, Therapeutics, Nuclear Receptors, Translational Research, NASH
Frequently Asked Questions
Don't just read about them. Follow them.
BounceWatch watches GENFIT and millions of other companies. When one raises money, hires quickly or changes its product, we tell you the same day.
Compiled from the BounceWatch company index. We last looked at GENFIT on 7 Jun 2025. The 12 companies listed here were last checked between 11 Sep 2024 and 9 Jun 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
